Max Salfinger

8.5k total citations · 2 hit papers
113 papers, 5.7k citations indexed

About

Max Salfinger is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Max Salfinger has authored 113 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Epidemiology, 76 papers in Infectious Diseases and 29 papers in Surgery. Recurrent topics in Max Salfinger's work include Mycobacterium research and diagnosis (87 papers), Tuberculosis Research and Epidemiology (73 papers) and Infectious Diseases and Tuberculosis (16 papers). Max Salfinger is often cited by papers focused on Mycobacterium research and diagnosis (87 papers), Tuberculosis Research and Epidemiology (73 papers) and Infectious Diseases and Tuberculosis (16 papers). Max Salfinger collaborates with scholars based in United States, Switzerland and Hungary. Max Salfinger's co-authors include Linda M. Parsons, Ákos Somoskövi, David M. Warshauer, Arnold Louie, Mark R. Deziel, Tawanda Gumbo, Gerald H. Mazurek, Leonid Heifets, Charles L. Daley and Yvonne M. Hale and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Max Salfinger

110 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

2016 656 citations Charles L. Daley, Max Salfinger et al. Clinical Infectious Diseases profile →
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

2017 476 citations Charles L. Daley, Max Salfinger et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Salfinger United States	38	4.3k	4.1k	1.8k	723	589	113	5.7k
Martin J. Boeree Netherlands	51	5.4k 1.3×	4.9k 1.2×	1.5k 0.8×	910 1.3×	1.2k 2.1×	165	7.4k
Gail L. Woods United States	44	5.1k 1.2×	5.6k 1.4×	1.8k 1.0×	800 1.1×	1.2k 2.0×	196	8.8k
Sven Hoffner Sweden	39	5.1k 1.2×	4.3k 1.0×	1.8k 1.0×	1.8k 2.5×	198 0.3×	127	6.7k
J O Kilburn United States	30	3.3k 0.8×	3.2k 0.8×	1.1k 0.6×	889 1.2×	479 0.8×	52	4.6k
Kathleen D. Eisenach United States	50	7.5k 1.8×	7.0k 1.7×	3.8k 2.1×	1.3k 1.7×	256 0.4×	115	8.9k
Nina Singh United States	54	5.9k 1.4×	8.1k 2.0×	1.5k 0.8×	326 0.5×	473 0.8×	162	10.5k
Giovanni Fadda Italy	47	3.6k 0.8×	3.9k 1.0×	858 0.5×	1.2k 1.7×	287 0.5×	137	7.1k
Suhail Ahmad Kuwait	46	4.2k 1.0×	3.7k 0.9×	844 0.5×	877 1.2×	332 0.6×	255	6.3k
Eric L. Nuermberger United States	51	6.6k 1.5×	4.6k 1.1×	1.4k 0.8×	2.5k 3.5×	443 0.8×	169	8.1k
Phyllis Della‐Latta United States	46	2.4k 0.6×	1.8k 0.4×	570 0.3×	606 0.8×	320 0.5×	119	5.2k

Countries citing papers authored by Max Salfinger

Since Specialization

Citations

This map shows the geographic impact of Max Salfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Salfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Salfinger more than expected).

Fields of papers citing papers by Max Salfinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Salfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Salfinger. The network helps show where Max Salfinger may publish in the future.

Co-authorship network of co-authors of Max Salfinger

This figure shows the co-authorship network connecting the top 25 collaborators of Max Salfinger. A scholar is included among the top collaborators of Max Salfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Salfinger. Max Salfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown‐Elliott, Barbara A., Joseph O. Falkinham, David E. Griffith, et al.. (2025). Laboratory diagnosis of nontuberculous mycobacteria – an update – Part 1★: Epidemiology, environment sources, and guidance for the provider. Clinical Microbiology Newsletter. 52. 31–43.

Gebert, Matthew J., et al.. (2022). Methods of isolation and identification of nontuberculous mycobacteria from environmental samples: A scoping review. Tuberculosis. 138. 102291–102291. 2 indexed citations

Davidson, Rebecca M., Nabeeh A. Hasan, L. Elaine Epperson, et al.. (2021). Population Genomics of Mycobacterium abscessus from U.S. Cystic Fibrosis Care Centers. Annals of the American Thoracic Society. 18(12). 1960–1969. 43 indexed citations

Azizan, Azliyati, et al.. (2020). Association of genetic variations in the vitamin D pathway with susceptibility to tuberculosis in Kazakhstan. Molecular Biology Reports. 47(3). 1659–1666. 15 indexed citations

Banaei, Niaz, Kimberlee A. Musser, Max Salfinger, Ákos Somoskövi, & Adrian M. Zelazny. (2020). Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases. Clinics in Laboratory Medicine. 40(4). 535–552. 1 indexed citations

Somoskövi, Ákos & Max Salfinger. (2019). How Can the Tuberculosis Laboratory Aid in the Patient-Centered Diagnosis and Management of Tuberculosis?. Clinics in Chest Medicine. 40(4). 741–753. 1 indexed citations

Sharma, Kusum, Megha Sharma, Manish Modi, et al.. (2018). Comparative evaluation of Xpert MTB/RIF assay with multiplex polymerase chain reaction for the diagnosis of tuberculous meningitis. Tuberculosis. 113. 38–42. 20 indexed citations

Kelly‐Cirino, Cassandra, et al.. (2016). Novel multi-day sputum transport reagent works with routine tuberculosis tests and eliminates need for cold chain: Preliminary study of compatibility with the Xpert® MTB/RIF assay. Diagnostic Microbiology and Infectious Disease. 86(3). 273–276. 12 indexed citations

Ichikawa, Kazuya, Jakko van Ingen, Won‐Jung Koh, et al.. (2015). Genetic diversity of clinical Mycobacterium avium subsp. hominissuis and Mycobacterium intracellulare isolates causing pulmonary diseases recovered from different geographical regions. Infection Genetics and Evolution. 36. 250–255. 33 indexed citations

10.

Somoskövi, Ákos, Sevim Ahmedov, & Max Salfinger. (2013). It is health that is real wealth & not pieces of gold & silver. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Gumbo, Tawanda, Arnold Louie, Mark R. Deziel, et al.. (2007). Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin. Antimicrobial Agents and Chemotherapy. 51(11). 3781–3788. 276 indexed citations

12.

Adams, Lisa V., et al.. (2007). DOTS implementation in a post-war, United Nations-administered territory: Lessons from Kosovo. Respiratory Medicine. 102(1). 121–127. 5 indexed citations

13.

Raka, Lul, Gjyle Mulliqi‐Osmani, Linda M. Parsons, et al.. (2004). Etiology and susceptibility of urinary tract isolates in Kosova. International Journal of Antimicrobial Agents. 23. 2–5. 30 indexed citations

14.

Gumbo, Tawanda, et al.. (2004). Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling. The Journal of Infectious Diseases. 190(9). 1642–1651. 248 indexed citations

15.

Parsons, Linda M., Roland Brosch, Stewart T. Cole, et al.. (2002). Rapid and Simple Approach for Identification of Mycobacterium tuberculosis Complex Isolates by PCR-Based Genomic Deletion Analysis. Journal of Clinical Microbiology. 40(7). 2339–2345. 203 indexed citations

16.

Somoskövi, Ákos, et al.. (2001). Lessons From a Proficiency Testing Event for Acid-Fast Microscopy. CHEST Journal. 120(1). 250–257. 72 indexed citations

17.

Hale, Yvonne M., Gaby E. Pfyffer, & Max Salfinger. (2001). Laboratory Diagnosis of Mycobacterial Infections: New Tools and Lessons Learned. Clinical Infectious Diseases. 33(6). 834–846. 63 indexed citations

18.

Somoskövi, Ákos, Linda M. Parsons, & Max Salfinger. (2001). The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respiratory Research. 2(3). 164–8. 261 indexed citations

19.

Salfinger, Max & G E Pfyffer. (1994). The new diagnostic mycobacteriology laboratory. European Journal of Clinical Microbiology & Infectious Diseases. 13(11). 961–979. 85 indexed citations

20.

Salfinger, Max, et al.. (1989). Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Research in Microbiology. 140(4). 301–309. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact